Tag:
biotech insider trading
Latest Headlines
Latest Headlines
WSJ: Hedge fund's MedImmune profits spur SEC insider probe
The Wall Street Journal reports this morning that the big hedge fund SAC Capital Advisors is being investigated for possible insider trading related to AstraZeneca's $15 billion acquisition of
Troubled Genzyme launches probe into insider trading claims
With regulators negotiating a hefty fine for the issues that have plagued its Allston Landing plant, Carl Icahn at the gates demanding a top-level overhaul and patients in an uproar over continued
